HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy

NCT00866203 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

441

Enrollment

OTHER

Sponsor class

Conditions

High-Grade Lymphomas

Interventions

DRUG: HDS vs ProMECE/CytaBOM

Sponsor

Gruppo Italiano Studio Linfomi